Price:
Rs. 18,900.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: G0129
Frequently Asked Questions (FAQ's):
What is the MYD88 L265P mutation?
It is a genetic mutation in the MYD88 gene often found in specific lymphomas and blood cancers, affecting immune cell signaling.
Why is this test recommended?
Doctors prescribe this test to confirm diagnosis, determine disease subtype, and guide appropriate targeted therapy options.
What sample is required for the test?
EDTA whole blood sample is needed for performing this genetic analysis at Metropolis Healthcare.
How is the test performed?
The mutation is detected using advanced PCR or molecular techniques for reliable identification.
Who should undergo this test?
Patients suspected of Waldenström Macroglobulinemia, Non-Hodgkin Lymphoma, or having symptoms like fatigue, anemia, or nerve issues may be recommended this test.
Do I need fasting before giving the sample?
No fasting or special preparation is required for this test.
How long does it take to receive results?
The reporting time generally depends on the testing workflow at Metropolis Healthcare and is typically a few working days.
How do the results help in treatment?
Positive detection assists doctors in treatment planning, including the use of targeted therapies designed for MYD88-driven conditions